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Abstract 
Co-crystals are excellent materials for studying intermolecular interactions in the solid-state 
and can be used to further our knowledge of the balance between strong and weak 
intermolecular interactions. The O–HNarom synthon was chosen as the focus of this 
investigation of hydrogen bonding motifs. The starting materials selected all have two 
hydrogen bond donor and/or acceptor sites for the formation of extended networks. All 
molecules are also aromatic such that the influence of weaker ππ interactions can be 
included in the study. Two 33 grids of related co-crystals were produced from these starting 
materials and are reported in this thesis as part of an ongoing investigation into a broader set 
of co-crystals. 
A part of the work describes the investigation of co-crystals prepared by the combination 
of related benzenediol and diazine isomers taken from a 33 grid. The solid-state structures 
of each of the six starting materials are discussed briefly to describe the nature of 
intermolecular interactions involved in the single component crystals. Trends in hydrogen-
bonding patterns as well as the weaker interactions identified in the starting materials, can be 
used to recognise those in the subsequent multi-component crystals. Thirteen co-crystal 
compounds were obtained, of which twelve structures are novel. Each of these co-crystal 
structures is discussed in terms of intermolecular interactions and packing in the solid state. 
Hydrogen-bonding patterns and structural similarities are highlighted in related co-crystal 
structures as well as between co-crystals and their respective starting materials.  
The combination of benzenediol isomers with benzodiazine isomers yielded seven novel 
co-crystal structures in a second 33 grid is reported. The structure of phthalazine, which has 
not yet been reported, is included in addition to these co-crystals, while the structures of 
quinazoline and quinoxaline that were retrieved from the CSD are discussed briefly. Co-
crystal structures are discussed individually, focusing on the intermolecular interactions that 
are significant to the structural architecture of the compound. Certain co-crystals that display 
structural similarities with structures of the 33 grid, as well as with co-crystals presented in 
Chapter 3, are discussed in the relevant sections. 
Lastly, two extended pyridyl diyne ligands that were synthesised for use in future co-
crystallisation studies similar to those reported earlier are briefly highlighted. The crystal 
structures of the pure compounds and of a hydrate of one of the ligands were obtained and 
discussed briefly. To date only one of these structures has been reported in the literature. 
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Opsomming 
Mede-kristalle (co-crystals) is uitstekende materiale vir die studie van intermolekulêre 
interaksies in die vastetoestand en kan gebruik word om die kennis van die balans tussen 
sterk en swak intermolekulêre interaksies te verbreed. Die O–HNarom sinton is gekies as 
die fokus van hierdie navorsing van waterstofbindings motiewe. Die geselekteerde 
uitgangstowwe het almal twee waterstofbinding donor en/of akseptor posisies vir die 
formasie van uitgebreide netwerke. Alle molekules is ook aromaties sodat die invloed van 
swakker ππ interaksies ingesluit kan word. Twee 33 stel van verwante mede-kristalle is 
voorberei vanaf hierdie reagense en word gerapporteer in hierdie tesis as deel van ’n 
langdurige studie van ’n groter stelsel mede-kristalle.  
’n Gedeelte van die werk beskryf ’n ondersoek van mede-kristalle wat uit ’n kombinasie 
van verwante benseendiol en diasien isomere berei is om ’n 33 stel te maak. Die 
vastetoestand strukture van elk van die ses reagense is kortliks bespreek om die aard van 
intermolekulêre interaksies betrokke in die enkel-komponent kristalle te verduidelik. 
Tendense in patrone van waterstofbindings, sowel as dié van swakker interaksies kon 
geidentifiseer word deur die vastetoestandstrukture van die uitgangstowwe en uiteindelike 
multi-komponent kristalle te vergelyk. Dertien mede-kristalle is verkry waarvan twaalf nuwe 
strukture is. Elkeen van hierdie dertien mede-kristal strukture is beskryf in terme van 
intermolekulêre interaksies en die rangskikking in die vastetoestand. Waterstof-bindings 
patrone en verwantskappe tussen strukture is uitgelig in verwante mede-kristal strukture 
asook tussen mede-kristalle en hul afsonderlike uitgangstowwe.  
Die kombinasies van benseendiol isomere en bensodiasien isomere lewer sewe nuwe 
mede-kristalstrukture in ’n tweede 33 stel. Die struktuur van ftaalasien, wat nog nie in die 
literatuur gerapporteer is nie, is ingesluit saam met die mede-kristalle, terwyl die kinasolien 
en kinoksalien strukture wat vanaf die CSD verkry is kortliks beskryf word. Die mede-kristal 
strukure is individueel bespreek, en daar word gefokus op die intermolekulêre interaksies 
wat belangrik is vir die strukturele argitektuur van die verbindings. Sommige van die mede-
kristalle vertoon strukturele ooreenkomste met ander kristalle in die stel, asook met die 
voriges en word in toepaslike afdelings bespreek. 
Laastens, twee uitgerekte pyridyl diyne ligande wat gesintetiseer word uitgelig vir vir die 
gebruik in toekomstig mede-kristallisasie studies soortgelyk aan die reeds genoem. Die 
kristalstrukture van die suiwer verbindings en ’n hidraat van een van die ligande is verkry en 
word kortliks beskryf. Net een van hierdie strukture is al in die literatuur gerapporteer. 
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CHAPTER 1 
 Introduction 
 
 
Chapter 1 - Introduction 
“There is no more basic enterprise in chemistry than the determination of the geometrical 
structure of a molecule. Such a determination, when it is well done, ends all speculation as 
to the structure and provides us with the starting point for the understanding of every 
physical, chemical and biological property of the molecule.”1 
R. Hoffman in Determination of the Geometrical Structure of Free Molecules, 
MIR Publishers: Moscow, 1983. 
 
In most areas of chemistry, a crystal structure determination is seen as the pinnacle of the 
study – the end product confirming successful completion of a synthetic procedure. 
However, for supramolecular chemists it is merely the beginning.2 In 1993, Aakeröy and 
Seddon stated, in reference to the structure of a crystal, that “the structural information could 
be treated as the beginning of a new venture, leading to questions of far reaching and 
fundamental importance regarding the interrelationships between molecules and ions in the 
solid state”.2 Crystal structures, in most circumstances, represent a freeze-frame of molecular 
interactions, bonding and non-bonding, thus yielding important information regarding subtle 
interactions to be disentangled and applied to the design of supramolecular materials i.e. 
crystal engineering.2 A brief introduction to the concepts essential to the work is presented 
here, but it is by no means a complete review of these concepts.  
1.1 SUPRAMOLECULAR CHEMISTRY 
Supramolecular chemistry can be described as the investigation of the relationships between 
molecules rather than between atoms. According to Lehn “supermolecules (crystals) are to 
molecules and the intermolecular bond what molecules are to the atom and covalent bond.”3 
The concept of chemistry ‘beyond the molecule’4 was first proposed by Pepinsky5 and later 
by Schmidt.6 The field of supramolecular chemistry is applicable to a diversity of 
disciplines, all seeking to create new materials or to understand biological processes. The 
diverse nature of these systems has led to contributions from, and consequently 
collaborations between, physicists, theoreticians and computational modellers, 
crystallographers, inorganic and solid-state chemists, synthetic organic chemists, 
biochemists and biologists.1 Supramolecular chemistry thus provides a link between visual, 
computational and experimental chemistry.7  
The widespread interest in supramolecular compounds is due to the functionality of many 
of these compounds. Functionality is thought to be derived from specific structural elements 
within the crystal structure. In order for specific functionality to be implemented in the 
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design of new materials, a fundamental knowledge of the contributing factors is required. 
These aspects include the structure of individual molecules (e.g. the relationship between 
conjugation and colour of organic molecules) or the mode of aggregation of these molecules 
in the solid-state (e.g. polar ordering for conduction). One of the major objectives of the 
supramolecular chemist, at least during the early stages of the field, was to establish the 
characteristic forces responsible for the organisation of molecules in the solid state and to 
investigate how these forces can be manipulated and exploited. The accumulation and 
implementation of this information to construct solid-state materials is referred to as “crystal 
engineering”.   
Supramolecular systems that have been examined extensively include the inclusion 
compounds (host:guest systems) subdivided into clathrates,8 rotaxanes,9 calixarenes,10 
cyclodextrins11 and cryptands.1 Inclusion compounds are typically comprised of a ‘host’ 
framework (organic molecules, in most instances) that encapsulates a smaller ‘guest’ 
molecule. Other supramolecular species that are highly topical include metal-organic 
frameworks (MOFs)8-10, zeolite-like metal-organic frameworks (ZMOFs)12 and zeolitic 
imidazolate frameworks (ZIFs)13,14 – these are especially important in the area of gas storage 
and separation. Co-crystal compounds15-18 and polymorphism are supramolecular 
phenomena of special interest to the pharmaceutical industry.  
 
“Engineering implies function-oriented design of the superstructure, selection of the 
building blocks…,their assembly and characterisation, to end with evaluation of the 
properties of the resulting supramolecular aggregate.”15  
 Braga and Grepioni 
1.2 CRYSTAL ENGINEERING  
Crystal engineering as a scientific discipline is still in its infancy but is rapidly becoming one 
of the most intriguing, versatile and sought-after approaches to materials design. The 
foundation of crystal engineering is in the concepts of molecular recognition and self-
organisation. Recognition events between complementary molecular fragments gives rise to 
the organisation of molecules in the solid state.2 The recognition process relies on a number 
of factors for the assembly of a solid-state structure, including hydrogen bonding between 
molecular functional groups, complementary geometry of molecules i.e. (humps fit into 
bumps) and other directing factors (e.g. ππ interactions). Self-organisation is the basis 
upon which complex matter is formed and mechanisms are generally complex. Structures 
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that ‘self-organise’ can be designed to do so by selecting suitable components and 
interactions for supramolecular synthesis, and is considered self-organisation by design.  
Owing to their directional characteristics and structural consequences, intermolecular 
interactions are the cornerstone of crystal engineering with the potential of controlling 
assembly of molecular building blocks into infinite architectures.7 Crystal engineering then 
encompasses an “understanding of intermolecular interactions in the context of crystal 
packing and in the utilisation of such understanding in the design of new solids with desired 
physical and chemical properties”.16  
Statistical analysis of structures retrieved from databases, combined with ab initio 
investigations, is a prerequisite for examining intermolecular interactions. Data collected 
from such investigations are subsequently implemented in the synthesis of new functional 
compounds.7 Since crystal structures are built from a delicate balance of these interactions, 
an understanding of their strength and directionality, and subsequent control, is of vital 
importance.7  
It is recognised that recurring patterns often occur between molecules in the solid-state. 
These patterns can be used as building blocks that assemble via recognition between 
molecular fragments. Assembling a collection of robust building blocks (supramolecular 
synthons, Section 1.4) that interact in a specific, reliable and reproducible manner,3 is 
expected to contribute to the predicable organisation of molecules into supramolecular 
systems. Functionality of these materials could then be tailored by modification of the 
building blocks. The formulation of a hierarchy of these building blocks would constitute a 
substantial increase in control over the ‘self-organisation’ of these systems.  
1.3 INTERMOLECULAR INTERACTIONS 
Intermolecular interactions are regarded as the communication network between molecules, 
and are responsible for the organisation of these molecules into an ordered arrangement to 
make up the “supermolecule” or crystal. Typically, intermolecular interactions are either 
medium- or long-range. Medium-range forces are of an isotropic nature and influence 
molecular shape, size and close-packing.17 Examples include CH, CC and HH 
interactions. Long-range interactions, on the other hand, are electrostatic and highly 
directional, taking place between heteroatoms such as N, O, S, Cl, Br, I or between these 
atoms and C or H.17 The most prominent of these long-range forces in the solid-state is the 
hydrogen bond, which is discussed in more detail below, along with a number of other 
important interactions involved in the structures of this study.  
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“The strong hydrogen bond is the master-key of molecular recognition, and full control of 
this interaction will lead to mastery of supramolecular chemistry in general.”18  
Gautam R. Desiraju 
1.3.1  HYDROGEN BONDING 
The directing nature of the hydrogen bond in the solid-state brings with it control over 
physical processes apparent in the crystalline form such as optical properties, thermal 
stability, solubility, colour, conductivity, crystal habit and mechanical strength.2 The 
frequent occurrence, along with the strength and directional nature of the hydrogen bond, 
make it a robust and specific interaction in the supramolecular context.18  
The hydrogen bond is arguably regarded as the most important interaction in 
supramolecular chemistry and it is also ubiquitous in biological systems (DNA, protein-
binding, etc). Its versatility is conferred by an energy contribution between that of covalent 
and van der Waals forces,19 making it available for reversible reactions. These are especially 
important in biological systems.  
Hydrogen bonding is divided into three main categories: very strong, strong and weak, 
according to strength and directionality (Table 1.1). The intermolecular forces involved, 
namely covalent, electrostatic and dispersion forces, influence the strength and directionality 
of the bond.20 There have been numerous studies on hydrogen bonding providing an 
abundance of information on the subject.15,18-21 
The geometry of a typical hydrogen bond between a donor atom (D) and an acceptor atom 
(A), related by an angle θ, is shown in Scheme 1.1.  
 
 
D H
A Y

Scheme 1.1 Definition of the hydrogen bond of the type D–HA–Y.18 
 
The simple two centred D–HY hydrogen bond, as shown in Scheme 1.1, tends towards 
linearity with θ values in the range 150-180°.17 Contact distances less than the sum of the 
van der Waals radii of the interacting atoms D and A, and θ angles that are near linear, are 
characteristic of strong hydrogen bonds.15  
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Table 1.1: Some properties of strong, moderate, and weak hydrogen bonds; adapted from a table in “The Weak 
Hydrogen Bond in Structural Chemistry and Biology.”19 The numerical data are guiding values only.20  
 Very Strong Strong Weak 
Interaction type Strongly covalent Mostly electrostatic Electrostatic / dispersive 
Bond Energy / -kcal mol-1 15-40 4-15 <4 
Examples  [FHF]- OHOC CHO 
 [NHN]+ OHOH OHπ 
Bond lengths  /     
HA 1.2–1.5 1.5–2.2 2.0–3.0  
Lengthening of DH /  0.08–0.25 0.02–0.08 <0.02 
DH versus HA DH  HA DH < HA DH  HA 
DA  /  2.2-2.5 2.5-3.2 3.0 –4.0 
Bonds shorter than van der 
Waals radii 
100% Almost 100% 30-80% 
directionality Strong moderate Weak 
Bond angles, θ /° 170-180 >130 >90 
Effect on crystal packing Strong Distinctive Variable 
Utility in crystal 
engineering 
Unknown Useful Partly useful 
 
A broad definition of hydrogen bonds proposed by Pimentel and McClellen (1960) makes 
no assumptions about the nature of the bonding atoms and therefore includes borderline 
donors and acceptors.19 Pauling provided a more expansive definition in a chapter on 
hydrogen bonding found in The nature of the chemical bond stating that “under certain 
conditions an atom of hydrogen is attracted by rather strong forces to two atoms, instead of 
only one, so that it may be considered to be acting as a bond between them”.19 He 
implemented a further restriction, stating that a hydrogen bond can only form between 
electronegative atoms as the interaction is electrostatic in nature.19 However, the most 
accepted definition of a hydrogen bond is that ‘a hydrogen bond exists where there is 
evidence that it exists’.2 
Under normal circumstances, the location of an atom is based on the centres of gravity of 
the nucleus and its electron shell, which are in good agreement.20 Because the hydrogen 
atom consists of only a single electron, paired with the nucleus, the exact location of the 
atom becomes difficult to assign accurately.20 This is because, when bonded to 
electronegative atoms by covalent interactions, the average position of the hydrogen electron 
is skewed towards the more electronegative atom and so the centres of gravity of the nucleus 
and electron no longer coincide.20 Where, then, is the hydrogen atom located? A 
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combination of neutron and X-ray diffraction analysis provides the most accurate positional 
data. Neutron diffraction locates the position of the nuclei, while X-ray diffraction 
determines electron-density maxima of the atoms.20 Despite neutron diffraction being the 
more accurate technique for locating atomic nuclei, X-ray diffraction is more widely 
accessible for routine structure determination. For hydrogen positions located by X-ray 
diffraction to be considered acceptable, the D–H bond is generally “normalised”. This is 
achieved by relocating the hydrogen atom (electron centre of gravity) along the D–H vector 
to a position corresponding to an averaged internuclear distance (approximate proton 
position) determined by neutron diffraction.20 Standard bond lengths (in Å) currently in use 
are O–H = 0.983, N–H = 1.009, C–H = 1.08320 and Carom–H = 0.950 For the purposes of this 
study, focus is placed on the DA distance of the hydrogen bond, as it is more accurately 
determined, although reasonable D–A distances have been included for completeness.  
The utility of the hydrogen bond stems from its long-range character, which is important 
in the organisation of molecules into predictable arrays.19 It has been argued that these 
interactions are felt by molecules as they approach one another, prior to nucleation in the 
solution-state, before dispersive interactions determining close-packing and stabilization 
energies are felt.19 Desiraju and Steiner summarise the influence of the hydrogen bond in the 
solid-state, in their book The Weak Hydrogen Bond in Structural Chemistry and Biology, 
with the following statement “the hydrogen bonds (weak and strong) determine the general 
connectivity patterns of molecules, while the isotropic interactions determine both 
intramolecular conformations and intermolecular close-packing within the basic scaffolding 
established by the hydrogen bonds.”  
It is generally accepted that the stronger hydrogen bonds are key in effectively controlling 
the crystal and supramolecular structure of a molecule. These include OHOC, 
NHOC and OHOH bond types.19 In contrast, weak interactions are involved 
to a lesser extent and their influence on the packing arrangement of the crystal structure can 
vary. This is due to the electrostatic nature of the bond that is modified by variable 
dispersive and charge-transfer contributions that are dependent on the donor and acceptor 
atoms.19 Examples of weak interactions are OHPh and CCHO types.19 The 
majority of strong hydrogen bonds observed during this study are the O–HN and, to a 
lesser extent, O–HO bonds. Typical DA distances of the O–HN interaction, 
determined by a CSD survey, occur in the range 2.60–2.90 Å with θ angles of 150–180°. 
These parameters are comparable to those of O–HO interactions.  
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Weakly directional hydrogen bonds are difficult to describe in terms of their impact on 
the packing of a crystal structure as they are often overshadowed by much stronger 
interactions. The weak hydrogen bond is differentiated from strong hydrogen bonds by the 
moderate to low electronegativity of the donor and/or acceptor atoms.19 Interactions of this 
type influence the crystal structure to varying degrees, of which three roles are apparent – 
innocuous, supportive or intrusive. Innocuous bonds have little impact on the structure, 
supportive bonds are congruent with the orientation requirements of other interactions in the 
structure, and weak hydrogen bonds that appear to steer packing are regarded as intrusive.19 
The C–H(O,N) type interactions are arguably the most important of the weakly 
directional forces in a range of chemical and biological systems.17 CO contact distances of 
between 3.0–4.0 Å are typical of these interactions, with θ angles ranging from 100–180° 
with an increased frequency between 150–180°.17 The reciprocal (O,N)–HC are 
uncommon owing to the electropositive nature of the carbon atom as well as steric 
hinderance for most sp3 hybridised atoms.17 For a carbon atom to act as a hydrogen bond 
acceptor it requires additional electronegativity, which can be supplied in the form of 
unsaturated C–C bonds such as alkynes, alkenes and aromatic rings in which electrons are 
delocalised over the contributing atoms.17  
1.3.2  CLOSE PACKING 
Kitaigorodskii has suggested that the phenomenon of close packing is “the manifestation of 
the maximisation of favourable isotropic van der Waals interactions”.1,22 In essence, 
molecules tend to pack efficiently, occupying all available space, while maximising 
energetically favourable van der Waals contacts.22 A simplification of the principle is that 
humps fit into bumps, much like the ‘lock and key principle’ in biological enzymatic 
systems. The fulfilment of close-packing within a crystal structure mostly results in the 
utilisation of only a small number of space groups, namely P21/c, P, C2/c, P21 and 
P212121.23  
1.3.3  πACCEPTORS 
Acceptors of this type are generated by moieties such as alkenes (CC), alkynes (CC) 
and, in most instances, aromatic rings. Here focus is placed on the aromatic type acceptors as 
they are more established and exhibit specific interaction motifs. Aromatic entities have the 
capacity to interact with one another in two common orientations, namely face-to-face 
(stacking interactions) and edge-to-face (also known as T-shaped) (Figure 1.1). The face-to-
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face conformation or ππ stacking can be eclipsed or offset (also referred to as slipped π-
stacks or skewed stacks).24 A similar charge of electron clouds, in close proximity, is 
compensated for by adopting the offset conformation and is preferential for identical 
interacting molecules.25 Eclipsed face-to-face stacking appears to be more favourable if the 
participating molecules are dissimilar and/or have complementary electron distributions.  
    
Figure 1.1 The different types of ππ 
interactions found between aromatic rings.30  
Figure 1.2 Two typical herringbone packing 
types – Gamma and sandwich herringbone.30  
 
Eclipsed face-to-face stacking yields a characteristic graphitic layering, whilst edge-to-
face interactions can be credited for the familiar herringbone packing pattern (Figure 1.2, 
left) commonly found in the structures of small aromatic molecules.1 Acceptable plane 
separation for the parallel stacked, and offset type stacking is approximately 3.3–3.8 Å.26 
Edge–to–face centroid–to–centroid distance can be as long as 5 Å.24  
Geometrical criteria are also an important consideration when studying aromatic 
molecules in the solid state. Aromatic molecules are generally disc shaped, which lends to 
efficient stacking of the molecules but also creates intermolecular space surrounding the 
edges.24 A factor determining the packing mode adopted by the molecules is the area of the 
aromatic ring compared to its thickness. Molecules with relatively small areas are likely to 
form edge–to–face interactions, that assemble in the crystal to form a herringbone pattern.24 
Offset interactions tend to be preferred with increasing area of the molecules. The sandwich 
herringbone motif is an intermediate between the gamma herringbone and offset patterns.24 
Larger, fused aromatic hydrocarbons pack predominately as offset stacks combined with 
edge-to-face interactions, thus yielding herringbone motifs.25 Stacking interactions are also 
applicable to heteroaromatic molecules, and especially polycyclic arenes where carbon is 
substituted by N, O, or S. However, in these cases, as the π systems increase in size, the 
offset pattern dominates over edge-to-face interactions.24  
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1.3.4  LONE-PAIRπ INTERACTIONS 
The lone-pairπ interaction has only recently been accepted by some within the 
supramolecular community as a supramolecular interaction. This interaction appears to be 
most evident in bio-macromolecules where it was first identified by Egli and colleagues in a 
left-handed Z-DNA duplex,27 while it has more recently been found to exist in small 
molecular host-guest systems and is reported to be energetically favourable.27 The 
intermolecular contact distance between the electron-rich atom and any of the six atoms of a 
(hetero)aromatic ring is limited to <4 Å and the distance to the centroid of the ring also does 
not exceed 4 Å.27  
1.4 THE SUPRAMOLECULAR SYNTHON 
“Supramolecular synthons are structural units within supermolecules which can be formed 
and/or assembled by known or conceivable synthetic operations involving intermolecular 
interactions.”3 Care should be taken not to confuse synthons with the intermolecular 
interactions involved in synthon construction in a structure. An interaction utilises chemical 
recognition between components, whereas a synthon relies on both chemical and geometrical 
aspects of the interaction.3 The intermolecular interaction forms an integral part of the 
synthon and, on occasion, the synthon and the interaction involved cannot be differentiated 
from one another. The OHNarom is an example of such an occurrence (Figure 1.3). 
Distinction is also made between a supramolecular synthon and the functional group of a 
molecule. The most basic difference here is in the type of bond utilized to assemble these 
entities – a functional group is covalently bonded (e.g. carboxylic acid, alcohol, amide), 
while a synthon is a hydrogen bonded motif constructed from complementary functional 
groups. Functional groups are often used in the creation of supramolecular synthons via 
intermolecular interactions.  
 
 
Figure 1.3 A supramolecular synthon OHNarom formed from the OHN hydrogen 
bond. Functional groups are marked by the green circle (alcohol) and square (Narom). 
 
Two categories of supramolecular synthon exist – the homosynthon, formed from self-
complementary donor and acceptor groups e.g. carboxylic acid dimer/catemer (a, Scheme 
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1.2), and the heterosynthon, comprised of different, yet complementary donor and acceptor 
groups (examples include acid–pyridine (c), hydroxyl–pyridine (b), acid–amide (e) etc.).28 In 
order for heterosynthons to form, interactions must be more favourable than in the 
homosynthon.  
 
Scheme 1.2 Supramolecular homosynthons (a, b) and heterosynthons (c, d, and e). 
Figure taken from Cryst. Growth Des., 2008, 8, 4533.28
1.5 CO-CRYSTALS 
Co-crystals, although not considered to be a new class of supramolecular compounds 
(quinhydrone was first reported29 in 1844), have only recently come to the forefront of 
supramolecular chemistry. However, the impact they have made in the CSD is still low, 
comprising only 1951 entries, ca. 1%, of all purely organic entries.28 Co-crystals have 
garnered much controversy30-32 over the past decade, both with regard to nomenclature and 
constitution. This raises the question: what is a co-crystal? All agree that a co-crystal is a 
“multi-component molecular crystal”, i.e. a crystalline material comprising more than one 
component in the same lattice.33 There is, however, discrepancy over the molecular 
components since the term “multi-component molecular crystals” encompasses a number of 
molecular assemblies, viz. solvates, hydrates, clathrates, inclusion compounds, etc. It is 
generally accepted that a co-crystal should consist of neutral molecules. A number of 
researchers14,34,35 have imposed further restrictions, limiting starting materials to compounds 
that are solid under ambient conditions. This limitation has led to disagreement concerning 
classification of multi-component molecular crystals not prepared from solid materials. How 
a crystal prepared from a solid and a liquid or a liquid–liquid combination is categorised 
remains to be addressed and it is the opinion of the author that the states of the starting 
materials should be irrelevant when investigating the properties of the end product. It seems 
absurd to distinguish between “co-crystal” compounds based on physical composition of the 
starting materials, especially if these compounds are clearly part of a series of related 
compounds. Despite inconsistencies, the term “co-crystal” will most probably continue to be 
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used as a synonym for “multi-component molecular crystal” simply because it is more 
straightforward.32  
Co-crystals can be prepared by many different crystallisation methods. Slow evaporation 
from solution is the method of choice, although grinding or solvent-assisted grinding 
(Section 1.8) techniques are gaining in popularity. Care should be taken when considering 
components since co-crystallisation is reliant on the resulting heteromeric species being 
more favourable than the homomeric form of either constituent.2 The use of synthons in this 
regard has received widespread success.2 Etter34 established a set of guidelines for the 
effective combination of co-crystal components (synthons) into a somewhat predictable 
array. The most significant of these observations is that “all good proton donors and 
acceptors are used in hydrogen bonding e.g. phenols, carboxylic acids, amides, imides, etc.” 
The hydrogen bonds then form in a hierarchical fashion, with the best-donor bonding to the 
best-acceptor then the second best-donor to the second best-acceptor and so on.34 Further 
elucidation of a hierarchy of these synthons in a competitive environment would be 
instrumental in co-crystal engineering and vice versa. Co-crystals are ideally suited for 
investigating synthons in a competitive environment owing to their modular nature, and by 
definition, must be composed of two (or more) components.28 Investigations of this nature 
are already under way.6,37 
Etter and co-workers were the first to introduce the use of co-crystals as a means of 
studying packing patterns, hydrogen-bond motifs and intermolecular forces, and they also 
established a classification system used to describe these patterns.7 This classification is 
known as Graph Set Notation and is discussed further in Section 1.7. 
Co-crystals have become an area of wide interest in terms of the fundamental aspects of 
molecular-recognition-driven assembly processes35 as well as applications in areas of host–
guest compounds, nonlinear optics (NLO), organic conductors, modifications of 
photographic films,36 or coordination polymers.28 However, the most active area of co-
crystal research is that of pharmaceutical co-crystals. 
1.5.1  PHARMCEUTICAL CO-CRYSTALS 
Pharmaceutical co-crystals can be described as a subset of co-crystals that form between an 
active pharmaceutical ingredient (API) and a co-crystallising agent (CA) that are both solids 
under ambient conditions.36 The propensity for APIs to form co-crystals is driven by the 
location of hydrogen bonding moieties on the exterior of the molecule that are thus 
accessible to co-crystal formers.36 This characteristic has, in the past, been detrimental as 
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such molecules are inclined to form polymorphs as well as solvates or hydrates in an 
unpredictable manner. However, the use of co-crystal forms of APIs in pharmaceutical 
preparations has contributed increased stability as well as improved physicochemical 
properties of these APIs. Prior to co-crystal forms, APIs were limited to formation of salts, 
polymorphs, hydrates and solvates, each with their own obstacles.37 The formation of novel 
API co-crystals is limited only by the number of co-crystal formers available. Currently there 
are hundreds of potential co-crystallising agents that comply with GRAS (Generally 
Regarded As Safe) regulations, including food additives, that remain to be tested.36 Because 
the API is not covalently modified in the co-crystal form, it is anticipated that these new 
pharmaceutical co-crystals will afford forms of APIs with enhanced physical properties such 
as improved solubility, stability, hygroscopicity and dissolution rates.36 The nature of the 
interactions between molecules in co-crystals also creates the potential for use in isolation or 
purification of APIs during processing, after which the CA is removed prior to formulation.36  
Because co-crystals present the possibility for an increased number of API formulations, 
protection of intellectual property is an essential part of the scientific process. As with most 
industries, safeguarding of intellectual property (IP) is essential to a company’s economic 
growth. Pharmaceutical companies are particularly dependent on meticulous IP protection 
owing to the nature of the industry – drug formulations undergo years of research and 
development, followed by rigorous testing and clinical trials, to ensure that all regulations 
are met before the product can eventually be marketed.38 Patents are the means by which 
scientific and technological inventions are safeguard and there are three criteria that must be 
met for an invention to be considered patentable: novelty, utility and non-obviousness. 
Certainly, co-crystals easily fulfil the novelty criterion as new and distinct solid-state 
structures. The lack of patents involving co-crystals suggests that the field is poised for 
potentially novel co-crystal inventions.38 The enhancement in solubility, dissolution rate 
profiles and consequently bioavailability of APIs in the co-crystal form has been shown to 
improve the therapeutic efficacy of the particular drug. This is evidence of the co-crystal’s 
utility. The non-obvious criterion is often the most difficult to satisfy and is said to be 
analogous to predictability.38 The solid-state structure of co-crystals is, at present, anything 
but predictable and a large component of research is focussed on the understanding of 
intermolecular interactions involved in the organisation of these molecules in the solid-state. 
Thus, co-crystals are, in general, non-obvious.  
Carbamazepine (CBZ) is an important anti-epileptic drug that exemplifies the 
improvement in physicochemical properties when co-crystallised. Carbamazepine has to date 
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manifested as four anhydrous polymorphs, a dihydrate, an acetone solvate and two 
ammonium salts. The co-crystal preparation with saccharin exhibits superior stability 
compared to the existing single-component crystal forms, showing favourable dissolution 
and suspension stability as well as a favourable oral absorption profile when administered in 
dogs. A recent report in the media (2007),33 disclosed the deaths of more than 4000 pets after 
food intake and was later found to be caused by a co-crystal of melamine and cyanuric acid. 
This co-crystal was found to be highly insoluble in water and resulted in acute renal failure. 
Both components are relatively non-toxic individually but toxic in co-crystal form at a 
concentration of 32 mg kg-1 body weight in cats. Both of these examples highlight the 
relevance of co-crystal studies in pharmaceutical formulations. 
1.6 POLYMORPHISM 
Mitscherlich (1822)39-41 first recognised that chemical compounds can have more than one 
crystal structure. McCrone (1965) later defined polymorphism as “a solid crystalline phase 
of a given compound resulting from the possibility of at least two different arrangements of 
the molecules of that compound in the solid state.”42 
Polymorphism can have both positive and negative implications, and the pharmaceutical 
industry will be used as an example. The discovery of a more stable form with superior 
physicochemical properties compared to the previous form(s) is an obvious advantage. 
However, polymorphs may be difficult to separate from one another. A bigger problem, still, 
is if one form is a sought-after drug component while another form may be highly toxic. The 
structural flexibility inferred by numerous polymorphic forms is an advantage when seeking 
suitable co-crystallising agents. Structural flexibility provides for multiple modes of self-
organisation or self-assembly with other molecules.41 Compounds adopting polymorphic 
forms also affect other areas of industry, including agrochemicals, explosives, dyes, 
pigments, flavours and confectionery products.41 Polymorphs can be distinguished from one 
another by studying their individual SCD structures and powder diffractograms, along with 
DSC analysis, IR spectroscopy, microscopy and a number of other techniques.23 
1.7 GRAPH SET NOTATION  
Graph set notation (or analysis) of a crystal structure is used to simplify the description of 
hydrogen bonding patterns. The idea, conceptualised by Margaret Etter (1990),34,43 is to 
designate all hydrogen bonding patterns into one of four simple motifs or a combination 
thereof. Hydrogen bonding motifs are classified as chains (C), rings (R), self bonded (S) (i.e. 
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intramolecular interactions) or discrete (D) (Figure 1.4).1 These four designators (G) 
combined with the number of hydrogen bond donors (subscript, d), acceptors (superscript, a) 
and the total number of participants (degree, n) in the motif, are considered to give a 
comprehensive description, , of the pattern.1 Similar hydrogen bonding patterns in a 
series of hydrogen bonded structures can be identified using this nomenclature. The general 
procedure in assigning graph set notation to a hydrogen bonded system is to first assign 
hydrogen bond motifs (consisting of only one type of hydrogen bond) followed by the higher 
order arrays that make up the network.2 The combination of graph set notation with a 
knowledge of supramolecular synthons and functional group similarities can be used to 
construct complex architectures from simple hydrogen bonding networks.  
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Figure 1.4 Examples of graph set assignments. The hexagons represent any organic ligand. Taken from 
Acta Crystallogr., Sect. B ,1990, 46, 256-262. 
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1.8 SOLVENT DROP GRINDING (Solid-state reaction chemistry) 
Crystalline products for X-ray diffraction studies can be obtained from slow evaporation of 
solvent,44 vapour diffusion,44 crystallisation from a melt, slurries45,46 and solvothermal47 
methods, to name but a few.48 Slow evaporation of solvent from a solution containing known 
molar quantities of co-crystal formers is the method of choice for co-crystallisations since it 
often yields single-crystals of suitable quality for SCD. As with any experimental technique, 
solvent evaporation has its drawbacks. It can be time-consuming waiting for crystals to 
grow, or establishing a suitable solvent system in which both components are soluble and, 
furthermore, starting materials may not be completely converted into the target product. In 
addition, the product may manifest in different forms (polymorphs) concomitantly or under 
different conditions. 
In particular, grinding has come into regular use in investigations of co-crystals and salts. 
This technique involves pulverising two (or more) components together for a given period of 
time to yield a multi-component product. The grinding process is carried out either manually 
with a mortar and pestle, or mechanically with a mill. The physical benefit of grinding is a 
reduction in particle size, thus increasing the surface area available for reaction;49 the 
mechanical energy put into the process generates enough heat to induce a number of solid-
state transformations, including crystalline to amorphous, amorphous to crystalline, 
polymorphic conversion as well as solid-state reactions.49  
A variation on the neat grinding method is solvent–assisted grinding, also referred to as 
solvent–drop grinding (SDG), which incorporates the use of a minimum of solvent (usually 
3–5 drops). The addition of solvent supposedly increases the degrees of freedom of the 
molecules, enhancing the occurrence of molecular collisions. It can also act as a catalyst and 
possibly even provide tiny co-crystal seeds.50  
The product of a grinding experiment is in general a micro-crystalline material that can be 
analysed by PXRD. It is, in some cases, possible to elucidate the single-crystal structure of 
this material via ab initio48 calculations (Rietveld refinement) from PXRD results to yield a 
3-D representation of the crystal structure. If this is not possible, the micro-crystals can be 
used to seed a saturated solution of the starting materials affording single crystals for SCD 
analysis. A PXRD pattern is then simulated from the crystal structure for comparison with 
the data obtained from the solvent-drop grinding experiment.   
Mechanochemical preparation of co-crystalline material is particularly appealing as it can 
be incorporated into high-throughput synthesis of new materials, which can rapidly be 
screened by PXRD analysis. The speed with which these products can be produced and 
 1-16
Chapter 1 - Introduction 
analysed offers the potential of testing an increased number of variables, including 
temperature, concentration gradients, various solvent systems (polar, non-polar) and grinding 
duration.51 In addition to these benefits, solvent-drop grinding is a cheaper, ‘greener’ and 
less time-consuming method of compound preparation.48 However, other techniques should 
not be disregarded since, in some instances, solvent plays an important role in the 
arrangement of the molecules and the resultant crystal structure. 
1.9 ASPECTS OF THIS STUDY 
For the chemist not fully versed with the intricacies of co-crystals, the effort of bringing 
together different molecules into a single crystalline compound may seem trivial.52 The 
complexities involved in bringing together two or more molecules without making or 
breaking covalent bonds while maintaining a level of control over intermolecular 
interactions, as well as the manner in which molecules are connected, is anything but 
trivial.52 The formation of crystalline compounds involves a delicate balance between strong 
and weak intermolecular interactions as well as a measure of self-recognition and subsequent 
assembly of complementary molecules. Co-crystals offer the opportunity to investigate the 
intricacies of supramolecular interactions of organic compounds in a relatively controlled 
environment. Components can be selected from a variety of readily available compounds 
and/or novel molecules can be designed as required. The design of novel components 
provides the prospect of investigating specific aspects of the interactions in question. Focus 
has recently been placed on developing a hierarchy28,53,54 of intermolecular interactions 
based on supramolecular synthons by placing them in competitive environments. The 
potential application of an established hierarchy is invaluable for the furthering of crystal 
engineering. Following this hierarchy, co-crystal components can be selected or designed 
such that binary, ternary and higher level compounds can be prepared with relative 
predictability, and thus impart a desired function to the final product.  
The objective of this study is not to establish a hierarchy of synthons, but rather to 
determine the positional effects of donor and acceptor atoms about aromatic rings in the 
formation of hydrogen bonds in a relatively controlled environment. The data obtained from 
this type of study can be used to tailor the design of novel crystalline compounds in 
conjunction with the knowledge of synthon hierarchy. Apart from the design aspect, these 
data can be considered to be a contribution to the further understanding of these non-
covalent forces in the solid-state. 
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The principle aim of this study is to prepare numerous co-crystals and investigate the 
intermolecular interactions concerned with the formation of these compounds. Nineteen 
novel co-crystal structures are reported here, and these are supplemented by data retrieved 
from the Cambridge Structural Database (CSD).  
The opportunity to study a closely related group of compounds is provided by the 
relatively simple starting materials. The hydrogen bond donors (benzenediol isomers) are 
selected because of their structural flexibility and dual donor-acceptor character. Although, 
not all of these compounds have polymorphic forms, each of the hydroxyl hydrogen atoms 
of each molecule can be located in one of at least two positions. It has been found that the      
Car–O–H groups are predominantly co-planar with the aromatic rings of the molecule. A 
brief CSD survey revealed this to be the case in the majority of structures containing the 
aromatic hydroxyl group. Although it is assumed that this is because of the delocalised        
π-electrons of the ring that repel the hydrogen atom of the hydroxyl group, further 
investigation is required. The diazine molecules are known as an important class of 
molecules from which pharmacological compounds can be synthesised and the capacity to 
form co-crystals is advantageous with regard to the potential for forming products with 
improved physicochemical properties. The complementary diazine acceptor molecules are 
weakly basic compounds ideal for co-crystal formation. The monocyclic and bicyclic diazine 
molecules were selected as acceptors owing to their similarity in N–atom placement about 
their aromatic rings. This offers the opportunity to investigate the influence of increased 
molecular size on the arrangement of the crystal structure. A larger surface area in the 
benzodiazine molecules is expected to have increased space requirements, although an 
increased surface area lends to formation of stronger ππ interactions. The chemical aspects 
of the interactions are not as apparent as the geometrical features. The chemical relationship 
between the two groups of acceptors is apparent in a comparison of basicity of the 
molecules. An almost identical trend is observed between the monocyclic and bicyclic 
diazine molecules (Table 1.2)55 with basicity decreasing as N–atoms become more remote 
from one another i.e. the ortho configuration is more basic than meta, with para being least 
basic. Phthalazine (BN23) is the most basic acceptor molecule with a pKa value of 3.50. 
Adjacent N–atoms located in the 2,3-positions make BN23 more basic than the monocyclic 
N2, with N–atoms situated in the 1,2-positions. Both hydrogen bond donor and acceptor 
molecules utilised here have the capacity to take part in more than one hydrogen bond, 
allowing formation of extended hydrogen bonded networks.  
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Donor and acceptor molecules are combined with the intention of using the OHNarom 
synthon. In this instance, the synthon is synonymous with the interaction between molecules. 
The alcohol moiety is the second most prominent functional group identified in the CSD 
after the ethers and is found in 33% of all prescription drugs (Table 1.3).28 Indeed, 74% of 
the 25 035 molecular alcohol entries28 retrieved from the CSD form heterosynthons with 
various acceptor groups. Of the 228 structures that contain alcohol and aromatic nitrogen 
atoms exclusively, 78% form the OHNarom synthon.28 This provides a sound foundation 
for co-crystallisation experiments using the OHNarom synthon.  
 
Table 1.2  The εHOMO, pKa and ionisation energy IE values of selected diazine molecules.55 
Molecule -εHOMO/Eh pKa IE/eV Molecule -εHOMO/Eh pKa IE/eV 
N2  
N
N
 
0.3797 2.33 10.41 BN2 
N
N
 
0.3270 2.30 9.10 
    BN23  
N
N
 
0.3317 3.50 9.07 
N3  
N
N
 
0.3752 1.30 10.61 BN3 
N
N
 
0.3256 1.90 9.08 
N4 
 N
N
 
0.3588 0.70 10.18 BN4 
N
N
 
0.3220 0.65 9.00 
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Table 1.3 Cocrystal Design: % Occurrence of Functional Groups in APIsa. Table taken from T. R. Shattock, K. 
K. Arora, P. Vishweshwar and M. J. Zaworotko, Cryst. Growth Des., 2008, 8, 4533-4545. 28 
 
 
The co-crystal compounds documented here were prepared either by slow evaporation of 
solvent or by a variation of solution seeding from material obtained via solvent-drop 
grinding. Single-crystal X-ray diffraction was used for structure elucidation with 
supplementary PXRD and DSC analyses. Hirshfeld surfaces, and fingerprint plots generated 
from these surfaces, provide an additional visualisation tool and theoretical calculations 
contribute to specific findings of relevant structures – α and β forms of O4N2 and the two 
scenarios of O4N3.  
Discussion of the compounds prepared is structured into two main chapters (Chapters 3 
and 4) according to the types of acceptor molecules used (diazine or benzodiazine). 
Structural elements are highlighted in each structure and similarities between compounds are 
discussed. A third chapter (Chapter 5) discusses compounds to be used in future co-crystal 
studies and the final chapter (Chapter 6) provides a summary of findings and a few general 
remarks regarding observations made during the study. 
 
A note on nomenclature:  
A systematic naming scheme for co-crystal compounds has not yet been established. 
Therefore, for the purposes of this study, an abbreviated system will be implemented. All 
starting materials are either ortho (1,2), meta (1,3) or para (1,4) substituted phenol or 
pyridine molecules. Therefore, starting materials are named according to the type of 
substituents (O,N) and its position about the ring, using IUPAC nomenclature, i.e. catechol 
(1,2–benzenediol) will be O2, and pyrimidine (1,3-diazine) will be N3. The resulting co-
crystal of catechol and pyrimidine is assigned O2N3. The benzodiazines will be named in a 
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similar manner, using the prefix B for benzo, to distinguish bicyclic rings from the 
monocyclic diazines, i.e. phthalazine (2,3–benzodiazine) will be BN23. When two forms 
exist, with different molar ratios, they will arbitrarily be assigned α and β.  
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Chapter 2 – Experimental and Analytical Techniques 
2.1 CO-CRYSTAL STARTING MATERIALS 
All compounds were supplied by Sigma-Aldrich and used without further purification. A 
summary of the co-crystal formers used is found in Table 2.1.The crystal structures of each 
of these starting materials are discussed in the relevant chapters. Solvents used include 
methanol (MeOH), ethanol (EtOH), acetonitrile (CH3CN), ethyl acetate (EtOAc), isopropyl 
alcohol (IPA), acetone, and distilled water (H2O), all of which were used as supplied.   
 
Table 2.1 Physical properties of the starting materials used in co-crystallisation experiments. 
Co-crystal former 
Molecular 
formula 
Mr /  
g mol-1 
mp  / °C 
Physical appearance 
(description) 
Density*  
/ g cm-3 
Catechol (O2) C6H6O2 110.11 100-103 white block crystals 1.419 (100 K) 
Resorcinol (O3) C6H6O2 110.11 110-113 white crystals 1.311(120 K) 
Hydroquinone (O4)      
α–form  C6H6O2 110.11 172-175 white crystals 1.378 (173 K) 
β–form  C6H6O2 110.11 172-175 white crystals 1.258 (293-303 K) 
γ–form  C6H6O2 110.11 172-175 white crystals 1.381 (283-303 K) 
Pyridazine (N2) C4H4N2 80.09 -8 yellow oil 1.346 (100 K) 
Pyrimidine (N3) C4H4N2 80.09 19-22 colourless crystals 1.320 (107 K) 
Pyrazine (N4) C4H4N2 80.09 50-56 white crystals 1.306 (184 K) 
Phthalazine (BN2) C8H6N2 130.15 89-92 yellow needles 1.328 (100 K) 
Quinazoline (BN3) C8H6N2 130.15 46-48 yellow crystals 1.322 (295 K) 
Quinoxaline (BN4) C8H6N2 130.15 29-32 light yellow crystals 1.362 (120 K) 
*Density obtained from crystal structures in the CSD1, apart from phthalazine. Temperatures of data collection 
are stipulated in brackets. 
2.2 CRYSTAL GROWTH 
In general, crystals were obtained via slow solvent evaporation, adaptations to this method 
are discussed in the appropriate sections. The general procedure was as follows: the relevant 
compounds were dissolved in a minimum amount of a suitable solvent and subjected to 
sonication to ensure complete dissolution. Some samples were subjected to a short period of 
heating using a heat gun if the solutes were not completely dissolved after sonication. The 
individual procedures for each of the co-crystal products are discussed below. 
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GRID 1: Benzenediol and diazine isomers  
β–O2N2 (1:2) 
To catechol (64 mg, 0.6 mmol) were added pyridazine (64 mg, 0.8 mmol) and a small 
quantity of acetone. Slow evaporation of the solvent at ca 4 °C afforded colourless plates of 
β–O2N2.  
 
O2N3 (1:1): 
To catechol (64 mg, 0.6 mmol) were added pyrimidine (64 mg, 0.8 mmol) and a small 
quantity of acetone. The solvent was left to evaporate slowly at ca 4 °C to afford colourless 
blocks of O2N3. 
 
O2N4 (2:1): 
To catechol (64 mg, 0.6 mmol) were added pyrazine (64 mg, 0.8 mmol) and a small quantity 
of acetone. Slow evaporation of the solvent at ca 4 °C afforded colourless rods of O2N4.  
 
O3N2 (1:1): 
To resorcinol (64 mg, 0.58 mmol) were added pyridazine (64 mg, 0.80 mmol) and a 
minimum of a 1:1 methanol/water solution. Slow solvent evaporation at room temperature 
afforded colourless shards of O3N2 in an oily orange residue.  
 
α–O3N3 (1:1): 
To resorcinol (64 mg, 0.6 mmol) were added pyrimidine (64 mg, 0.8 mmol) and a minimal 
quantity of acetone. Slow evaporation of the solvent at ca 4 °C afforded colourless plates of 
α–O3N3. 
 
β–O3N3 (2:1): 
Approximately stoichiometric amounts of resorcinol (64 mg, 0.6 mmol) and pyrimidine (64 
mg, 0.8 mmol) were ground with a mortar and pestle for approximately 5 min after addition 
of 3 drops of methanol. The solid material obtained was used as seeding material for a 
methanolic solution of the same components. Slow evaporation of the solvent afforded 
colourless rods of β–O3N3. 
 
 
 
 2-3
Chapter 2 – Experimental and Analytical Techniques 
α–O3N4 (1:1): 
To resorcinol (64 mg, 0.6 mmol) were added pyrazine (64 mg, 0.8 mmol) and a minimum of 
acetonitrile. The solvent was left to evaporate slowly to dryness affording colourless plates 
of α–O3N4. 
 
β–O3N4 (3:1): 
To resorcinol (64 mg, 0.6 mmol) were added pyrazine (64 mg, 0.8 mmol) and a minimum of 
acetonitrile. The solvent was then allowed to evaporate slowly to dryness to afford colourless 
plates of β–O3N4. 
 
α–O4N2 (1:1): 
To hydroquinone (88 mg, 0.8 mmol) were added pyridazine (80 mg, 1.0 mmol) and a small 
quantity of acetonitrile. Slow solvent evaporation in the absence of light afforded colourless 
plates of α–O4N2.  
 
β–O4N2 (1:2): 
To hydroquinone (88 mg, 0.8 mmol) were added pyridazine (80 mg, 1.0 mmol) and a 
minimum of acetonitrile. Slow solvent evaporation in the absence of light afforded 
colourless blocks of β–O4N2. 
 
O4N3 (1:1): 
To hydroquinone (88 mg, 0.8 mmol) were added pyrimidine (80 mg, 1.0mmol) and a 
minimum of acetonitrile. Solvent was left to evaporate slowly to dryness in the absence of 
light to afford colourless blocks of O4N3. 
 
O4N4 (1:1): 
To hydroquinone (88 mg, 0.8 mmol) were added pyrazine (80 mg, 1.0 mmol) and a small 
quantity of methanol. Slow solvent evaporation afforded colourless blocks of O4N4. 
 
GRID 2: Benzenediol and benzodiazine isomers  
O2BN23 (1:2): 
To catechol (11 mg, 0.1 mmol) were added phthalazine (15.6 mg, 0.12 mmol) and a 
minimum of acetonitrile. Slow solvent evaporation at room temperature afforded orange 
plates of O2BN23.  
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O4BN23 (1:2): 
To hydroquinone (11 mg, 0.1 mmol) were added phthalazine (15.6 mg, 0.12 mmol) and a 
minimum of acetonitrile. Solvent was left to evaporate slowly to dryness at room 
temperature yielding yellowish plates of O4BN23. 
 
O2BN3 (1:1) 
An approximate 1:2 molar ratio of catechol (22mg, 0.2 mmol) and quinoxaline (64 mg, 0.5 
mmol) was ground for 10 min on the lowest speed setting in a mechanical mill after addition 
of 3 drops of methanol. The solid product was rinsed into a glass vial with ethanol and the 
solvent was allowed to evaporate slowly at room temperature to yield yellow rod crystals of 
the 1:1 O2BN3. 
 
O3BN4 (1:2): 
To resorcinol (11 mg, 0.1 mmol) were added quinoxaline (15.6 mg, 0.12 mmol) and a 
minimum of acetonitrile. Slow solvent evaporation at room temperature afforded yellow 
blocks of O3BN4. 
 
α–O4BN3 (1:2) 
An approximate 1:2.5 molar ratio of hydroquinone (22 mg, 0.2 mmol) and quinazoline (64 
mg, 0.5 mmol) were ground for 10 min on the lowest speed setting in a mechanical mill after 
addition of 3 drops of methanol. A small sample of the ground material was dissolved in 
ethanol and allowed to evaporate to dryness to afford colourless blocks of α–O4BN3.  
 
β–O4BN3 (1.6:1) 
An approximate 1.6:1 molar ratio of hydroquinone (67.7 mg, 0.6 mmol) and quinazoline (50 
mg, 0.4 mmol) were ground for 10 min on the lowest speed setting in a mechanical mill after 
addition of 3 drops of methanol. The resulting solid product was dissolved in ethanol and 
transferred to a glass vial from which the solvent was allowed to evaporate to dryness at 
room temperature, yielding colourless blocks of β–O4BN3.  
 
O2BN4 (1:1 - ASU): 
An approximate 1:2.5 molar ratio of catechol (22 mg, 0.2 mmol) and quinoxaline (64 mg 0.5 
mmol) were ground for 10 min on the lowest speed setting in a mechanical mill after 
addition of 3 drops of methanol. A small sample of the ground material was dissolved in 
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ethanol and the solvent was allowed to evaporate to dryness to afford yellow rods of a 1:1 
O2BN4.  
2.3 PREPARATION BY SOLVENT–DROP GRINDING (SDG)  
Solvent-drop grinding experiments were carried out manually with an Agate mortar and 
pestle or mechanically using an in-house modified jigsaw (Makita, 50-60 Hz/500-3100 
strokes per min. (SPM)) instrument. The sample holder used for the mechanical grinding is 
an approximately 5 cm long stainless steel capsule with a 5 mm diameter stainless steel ball 
for grinding. Typically, the two sample components are loaded into the stainless steel 
capsule together with a few drops of solvent and the steel ball, and the capsule is then 
fastened into a bracket attached to the jigsaw blade.  
After preliminary grinding experiments, a general protocol was formulated in which 
samples were pulverized for 10 min at the lowest speed setting (500 SPM). The milled 
material was then scraped from the walls of the capsule and stored in a glass vial for further 
analysis. Residual material was washed from the stainless steel cylinder into a glass vial with 
ethanol that was then allowed to evaporate slowly with the expectation of forming suitable 
single crystals for SCD analysis.  
2.4 THERMAL ANALYSIS 
Differential Scanning Calorimetry is used to determine the difference in heat flow between a 
sample and a reference material (most often an empty pan), that are subjected to the same 
thermal program.2 Differences in temperature between the sample and reference infers that a 
thermal event has taken place; these events can be related to glass transitions, phase 
transitions (changes in heat capacity, solid-solid transition, eutectics, melting, sublimation 
etc.). DSC is used in this study to determine the onset temperature of a melt or phase 
transition. DSC is used in conjunction with PXRD to verify the preparation of a novel co-
crystal phase. 
Differential Scanning Calorimetry (DSC) was carried out using a TA Instruments Q100 
system under a N2 gas purge (flow rate of 50.0 ml/min) coupled to a cooling unit. A standard 
procedure was established and used for all compounds. Starting at an initial temperature of 
20 °C, the sample was cooled to -20.0 °C at a set ramp rate (either 2.5, 5 or 10 °C min-1), 
maintained at this temperature for 1 min, then ramped to approximately 10 °C above the 
melting point of the higher melting starting material, and then cooled back down to 20 °C. 
The procedure was subsequently repeated such that each sample completes two thermal 
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cycles per run. A 5 °C min-1 ramp rate was typically chosen for analysis with 2.5 °C min-1 
and 10 °C min-1 ramp rates used to corroborate the results obtained.  
Sample preparation was minimal in all cases: a powdered sample of approximately         
5-10 mg was placed in an aluminium pan which was non-hermetically sealed with vented 
aluminium lids. Reference pans were prepared in a similar manner. 
2.5 SOLUTION NMR 
Synthesised ligands and intermediate products (Chapter 5) were characterised using 1H and 
13C NMR experiments. These were performed on either a Varian Unity Inova 400 MHz 
NMR spectrometer or a 300 MHz Varian VNMRS NMR spectrometer. All spectra were 
collected at room temperature using standard procedures.  
2.6 SINGLE-CRYSTAL DIFFRACTION (SCD) AND ANALYSIS  
The determination of a material’s single crystal structure is arguably the most definitive of 
all characterising techniques available today. SCD is a non-destructive technique that utilises 
X-ray radiation to ultimately determine the atomic coordinates of a molecule(s) in the solid-
state. Solid-state materials yield characteristic diffraction patterns with reflection intensities 
for the constituting atoms and analysis of these parameters allows a 3-D structure 
determination from which vital information concerning chemical formula, bond lengths and 
angles as well as absolute configuration can be elucidated.  
In all cases crystals were immersed in paratone oil and a suitable crystal selected and 
mounted onto a MiTeGen mount that was then placed onto the goniometer head of the 
Single Crystal Diffractometer for data collection. X-ray intensity data were collected on a 
Bruker-Nonius SMART Apex diffractometer equipped with a fine-focus sealed tube and a 
0.5 mm Monocap collimator (monochromated Mo-Kα radiation,  = 0.71073 ). Data were 
captured with a CCD (Charge-Coupled Device) area-detector with the generator powered at 
40 kV and 30 mA. A constant stream of nitrogen gas is produced by an Oxford Cryogenics 
Cryostat (700 Series Cryostream Plus) coupled to the diffractometer for low temperature 
(100 K) data collection of all structures. On occasion crystals would deteriorate rapidly on 
removal from this nitrogen stream.  
SMART3 software was employed to implement an appropriate data collection strategy 
after a reliable unit cell had been determined. Standard ω-scans were used to obtain intensity 
data which were subsequently reduced and refined using SAINT4 software. A multi-scan 
absorption correction was performed utilising SADABS.5 All structures were solved by 
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direct methods using SHELXS-97.6 SHELXL-97 was employed within the X-Seed7,8 
environment to refine the resulting structure by full matrix least-squares based on F2. 
Thermal parameters, bond angles and hydrogen bonding patterns were used to distinguish 
between carbon and nitrogen atoms and all non-hydrogen atoms were refined 
anisotropically. Owing to the characteristics of the hydrogen atom (discussed in Chapter 1, 
Section 1.3.1), hydrogen atoms of the aromatic rings are placed using a riding model 
constraint (mn = 43) based on idealized coordinates and geometrical constraints.9 The 
distance constraint for an aromatic C–H interaction is given as 0.93 Å and increased by 0.02 
Å to compensate for the low temperature data collection so that bond lengths are 0.95 Å. 
Hydroxyl hydrogen atoms were located in Fourier difference maps and refined isotropically. 
Disordered structure refinement is discussed in the relevant sections (Chapter 3, Section 
3.2.6).  
2.7 POWDER X-RAY DIFFRACTION (PXRD)  
Powder diffraction analysis is another non-destructive technique used primarily to 
characterise solid materials. It is an especially useful tool in monitoring structural changes 
that may take place in the solid state. It can also be useful in the verification of the 
composition of a bulk sample from which a single crystal structure has been selected. This 
method is becoming more extensively used in a high-throughput analysis of compounds 
under investigation, particularly in the pharmaceutical industry, where time and money are 
of the essence.  
The powder diffractometer that was utilised for this study is a Bruker D8 ADVANCE 
model with Bragg-Brentano geometry using Cu Kα radiation ( = 1.5406 ) generated at 40 
kV and 30 mA and diffracted from the sample onto a Dynamic scintillation (point-type) 
detector for data capture.  
All samples were prepared in the same manner – gentle grinding with a mortar and pestle 
followed by sample loading into a standard sample holder or mounted onto a glass slide if 
there was insufficient sample to fill the holder. A general operating procedure was used for 
all samples – samples were scanned from 4–40° 2 at increments of 0.04° with 2 s scan 
steps. Data were collected at a constant room temperature of 22 °C.  
A number of aspects of PXRD need to be taken into account when analysing 
diffractograms – sample preparation is important to ensure uniform particle size to maximise 
precision of the data collection and to ensure high resolution in the resulting diffraction 
pattern. The phenomenon of preferred orientation can also affect the results such that some 
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peaks are more intense relative to others in the pattern. To counteract this, samples are 
generally rotated at a constant speed throughout data collection. However, samples in this 
study were not rotated since peaks below 5° 2 would be obscured by the lip of the sample 
holder when rotated, and the pattern obtained would be incomplete. When comparing 
experimental data with a pattern simulated from single-crystal data, the temperature at which 
the data is collected should be taken into account and any deviations justified. In this study 
all PXRD diffractograms were acquired at 22 °C (295.2 K) and all SCD structural data were 
collected at 100 K (-173.2 °C). Therefore, all predicted patterns are generally shifted slightly 
to the right assuming positive thermal expansion along all axes at the elevated temperature. 
This is owing to the inverse relationship between d and °2 in Bragg’s Law: 
 
 sin2dn  ,  
 
where  is the incident radiation wavelength, d is the reciprocal lattice spacing and  is 
the angle of the incident X-ray beam 
A decrease in temperature would bring about a contraction of the crystal’s unit cell 
dimensions, which are coupled to the d spacings within the crystal lattice. These, in turn, are 
inversely related to the angles measured in the diffraction pattern (2), thus explaining why 
the predicted pattern (collected at lower temperature) would be shifted slightly to the right. 
 
2.8 COMPUTER PACKAGES 
 CAMBRIDGE STRUCTURAL DATABASE (CSD) 
The Cambridge Structural Database1 (CSD) is a structural resource that allows one to search 
published single crystal as well as powder structural data using a single convenient interface. 
Restrictions (limits) can be imposed on the search in order to refine the data search. As of 1 
January 2009, 201 606 organic molecules and 248 408 inorganic structures have been 
deposited in the CSD. A wealth of knowledge can be obtained from a statistical analysis of 
compounds already present in the CSD, including understanding the nature of certain bond 
types (especially hydrogen bonds) and other intermolecular interactions and can be used in 
the identification of frequently occurring patterns and supramolecular synthons.10 The 
Mercury11 and Vista interfaces were also used to visually analyse the structures and 
compare the statistical data retrieved respectively.  
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 CRYSTAL EXPLORER 
Crystal Explorer12 is a computer package that utilizes calculated Hirshfeld surfaces13 of 
molecules within a crystal structure to determine the intermolecular interactions between 
particular molecules or for the crystal structure in its entirety. Hirshfeld surfaces are created 
by an extension of the weight function describing an atom in a molecule, to include the 
function of a molecule in a crystal.14 The isosurface generated from these calculations, with a 
specified weight function w(r) = 0.5, surrounds the molecule and by partitioning the electron 
density of the molecular fragments, delineates the space occupied by a molecule in a 
crystal.14 Hirshfeld surfaces can provide information about intermolecular interactions in the 
crystal as the surface is determined by both the enclosed molecule and its closest 
neighbours.14 Other molecular surfaces used to visualise and quantify molecular geometries 
such as the fused sphere van der Waals (or CPK) and smoothed Connelly surfaces do not 
have this advantage as they are designated only by the molecule itself.14 For quality data 
regarding intermolecular interactions to be extracted from Hirshfeld surfaces, the only 
prerequisite is that the crystal structures imported into the program are well-characterised 
with all hydrogen atoms located accurately.  
The equation used to define a Hirshfeld surface is w(r) = 0.5 where w(r) is the weight 
function described as  
 
 
 

moleculei crystali
ii rrrw )(/)()(  ; 
 
where i(r) is a spherical atomic electron distribution located at the ith nucleus.  
The surfaces incorporated in this study are all calculated using the dnorm function15 so that 
the contact distance is normalised according to the formula  
 
vdW
e
vdW
ee
vdW
i
vdW
ii
norm r
rd
r
rdd  , 
 
di  is the distance from the surface to the nearest atom interior to the surface; de is the 
distance from the surface to the nearest atom exterior to the surface (Figure 2.1). The sum of 
the two distances would give an approximate contact distance.  
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Surfaces generated are depicted using a sliding colour scheme (Figure 2.2), with contacts 
closer than the sum of their van der Waals radii highlighted in red, longer contacts in blue, 
while contacts approximately equal to the sum of van der Waals radii are white. 
      
Figure 2.1 Definition of the di and de 
distances in establishing the Hirshfeld 
surface.15  
Figure 2.2 The sliding colour scale of 
dnorm Hirshfeld surfaces taken from the 
Crystal Explorer online manual.14  
 
A 2-D fingerprint plot combining the di and de distances is a more visual representation of 
the relationship between these descriptors.14 The di, de pairs are binned in intervals of 0.01 Å 
and the colouring of each bin in the 2-D histogram is a function of the fraction of surface 
points in that bin. The sliding colour scale from blue (few points) through green to red (many 
points) indicates the concentration of points in each bin. Fingerprint plots (Figure 2.) provide 
a means of rapid comparison of two or more crystal structures by virtue of the fact that each 
plot is unique to a crystal structure and is highly sensitive to a molecule’s immediate 
environment.14 A number of interaction types have distinctive shapes in the 2-D plot that can 
be used to quickly identify these interactions in the crystal structure. Specific interactions 
can be highlighted in the plot by selecting the relevant atom types, these areas are shaded 
blue, while the remainder of the interactions are grey. The interactions highlighted in Figure 
2.3 are the most significant to this particular study and will be referred to in the descriptions 
of the structures reported.  
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OHNHCH  CC a) b) c) d) 
Figure 2.3 Selected characteristic patterns for symmetry–related interactions between molecules interior and 
exterior to the Hirshfeld surface. The blue areas highlight the specific interaction, while the grey areas represent 
the remainder of the intermolecular interactions. In each interaction type there are characteristic markers that 
can be identified. a)‘Wings’ represent CH interactions most often as C–Hπ interactions, b) the outer tails 
are indicative of NH interactions, c) OH interactions are represented by inner tails, and d) the concentrated 
green area on the diagonal is indicative of CC interactions, most often ππ type.16  
 
 SAINT+4 was used to convert raw crystallographic frame data to a set of integrated 
intensities with standard deviations, direction cosines, and XYZ centroids. This is 
achieved by an integration method similar to that reported by Kabsch,17 using 3-D 
profiling algorithms.  
 SADABS5,18 (Siemens Area Detector Absorption Corrections) is an application in the 
APEX suite used to scale and correct data collected on a Bruker AXS area detector 
utilising .raw files generated by SAINT+ 
 XPREP19 (Reciprocal Space Exploration) was used to determine crystal symmetry and 
space groups for single-crystal data by the analysis and manipulation of intensity data. 
Input files can be uncorrected .raw files obtained directly from SAINT+ or scaled .hkl 
files from SADABS.  
 X-Seed7,8 is a graphical software program used as an interface for the SHELX-97 
software suite used to solve and refine single-crystal data from .ins files (generated by 
XPREP) and the reflection files (.hkl) obtained from SADABS. X-seed also provides a 
platform for generating structural images using POV-RAY. Structures retrieved from the 
CSD can also be imported into X-Seed for packing analysis.   
 Structural images were rendered using POV-RAY20 (Persistence of Vision Raytracer) 
2.9 CHEMICAL MODELLING 
Theoretical modelling was performed by Dr Catharine Esterhuysen, and a summary of the 
results is included in the relevant sections. For calculations performed for comparison of 
stabilisation energies of structures α–O4N2 and β–O4N2, the positions of the hydroxyl 
hydrogen atoms in models, comprised of four molecules of hydroquinone and four or eight 
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molecules of pyridazine, were optimised using density functional theory (DFT) at the B971 
level of theory, utilising the 6-31G(d) basis set. Interaction energies between pairs of 
molecules were calculated by determining the difference in energies between single point 
calculations of the dimer at the B971/6-311G(d) level of theory, with the Counterpoise 
correction and those of the individual molecules involved in the interaction.  
For energy comparisons of Scenarios 1 & 2 of the crystal structure of O4N3, the positions 
of the hydroxyl hydrogen atoms in models containing one molecule each of hydroquinone 
and pyrimidine were optimised at the B971 level of theory, utilising the 6-31G(d) basis set. 
Interaction energies between pairs of molecules were calculated by determining the 
difference in energies between single point calculations of the dimer at the B971/6-311G(d) 
level of theory, with the Counterpoise correction, and those of the individual molecules 
involved in the interaction.  
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